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Cryptosporidium
felis Infection,
Spain
To the Editor: Coccidian proto-
zoans that belong to the genus
Cryptosporidium frequently cause
gastrointestinal infection in humans
and animals and are distributed
worldwide. Cryptosporidium hominis
and the cattle genotype of C. parvum
are responsible for most human infec-
tions. However, other species and
genotypes of Cryptosporidium, such
as C. felis, C. muris, C. meleagridis,
C. canis, C. parvum pig genotype, and
C. parvum cervine genotype, have
also been detected in stool samples of
immunosuppressed and immunocom-
petent patients (1). Since 1999, when
Pieniazek et al. described 3 cases of
C. felis infection in HIV-positive
patients (2), several studies have con-
firmed that this species can infect
humans. Recently, Muthsusamy et al.
described C. felis infections in 5 HIV-
positive persons in southern India (3).
In this article, we describe our experi-
ence with an imported case of C. felis
infection in Spain.
A pediatrician requested a para-
sitologic study for an immunocompe-
tent, 4-year-old boy with diarrhea.
The child came from an orphanage in
Calcutta, India; he had arrived in
Spain 10 days earlier after having
been adopted by a Spanish family.
Stool specimens were tested for a
wide panel of enteric pathogens,
including bacteria, viruses, and para-
sites.  Cryptosporidium oocysts were
detected by direct microscopic visual-
ization of the samples, which had
been concentrated by formalin–ethyl
acetate sedimentation and stained
with a modified Ziehl-Neelsen stain.
Results were also positive for
Cryptosporidium for samples tested
by using an immunochromatographic
(Crypto-Strip, Coris Bioconcept,
Gembloux, Belgium) (4) and an
immunofluorescent assay (Merifluor
Cryptosporidium/Giardia, Meridian
Diagnostics, Cincinnati, OH, USA).
DNA was extracted as described
elsewhere (5), purified with
polyvinyl-pyrrolidone, and stored at
–20°C in Tris-EDTA buffer. After
DNA extraction, PCR–restriction
fragment length polymorphism
(RFLP) analysis was performed by
using previously described protocols
based on the small subunit (SSU)
rRNA gene (6), with digestion of the
amplicon by the restriction enzymes
SspI for species diagnosis or VspI for
C. parvum genotype identification.
For DNA sequencing, PCR products
of the 18S rRNAgene fragments were
purified and used for direct sequenc-
ing in an ABI377 automated
sequencer (Applied Biosystems,
Foster City, CA, USA).
RFLP analysis showed a profile
distinct from those of C. hominis and
C. parvum cattle genotype and consis-
tent with the published patterns for
Cryptosporidium felis: 426 and 390
bp with SspI digestion; 476, 182, and
104 bp with VspI (6). The sequence of
the PCR product was determined, and
a comparison with all SSU rDNA
Cryptosporidium sequences available
in databanks showed 100% similarity
with the homologous fragment of C.
felis (GenBank accession no.
AF112575).
To date, >30 cases of human infec-
tion by C. felis have been reported in
the literature. Only 3 of them have
occurred in immunocompetent
patients: 2 in the United Kingdom (7)
and 1 in Peru (8). To our knowledge,
this is the first case of human C. felis
infection diagnosed in Spain. The
child had been in Spain for only 10
days, no pet animals lived in his new
home, and he had not gone to kinder-
garten. Consequently, the infection
was likely acquired in India.
The transmission route for the
unusual  Cryptosporidium species is
unclear. In the study by Matos et al.,
only 1 of 4 immunocompromised
patients with C. felis had been in close
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 9, September 2006 1471LETTERS
contact with cats at home (9). Unusual
cryptosporidial infections are not
restricted to immunocompromised
hosts, and further investigation of the
pathogenicity and epidemiology of
these infections is necessary to estab-
lish their effect on public health and to
identify risk factors for exposure and
measures for prevention. The identifi-
cation of species other than C. homin-
is and C. parvum that infect humans,
and the transmission routes of such
agents, has relevance for better under-
standing of the epidemiologic features
of cryptosporidiosis.
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Correction: Vol. 10, No. 5
In “Syndromic Surveillance in Public Health Practice, New
York City,” by Richard Heffernan et al., errors occurred.
On page 861, in Table 2, the numbers of visits indicated in
the headings for columns 3, 4, and 5 are incorrect. In the
corrected table, column 3, % age 13–39 y, n = 946,478; col-
umn 4, % age 40–64 y, n = 604,707; and column 5, % age
>65, n = 259,615. Additionally, a footnote has been added
to the column 2 heading: *Total number includes 7,266 vis-
its for which patients’ ages were unavailable.
The corrected table appears in the updated article at
http://www.cdc.gov/ncidod/EID/vol10no05/03-0646.
htm#table2
We regret any confusion these errors may have caused.
Corrections: Vol. 11, No. 6
In “Methicillin-resistant Staphylococcus aureus Hospi-
talizations,” by Matthew J. Kuehnert et al., an error
occurred. In Table 3, columns 3 and 5, the rates shown for
hospitalization with S. aureus and MRSA-related dis-
charge diagnoses were per 10,000 discharges, rather than
per 1,000 discharges, as indicated.
The corrected table appears in the updated article at
http://www.cdc.gov/ncidod/EID/vol11no06/04-0831.
htm#table13
We regret any confusion this error may have caused.
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